[Corrections] Correction to Lancet Diabetes Endocrinol 2025; 13: 591–99

Amylidi-Mohr S, Zennaro G, Schneider S, Raio L, Mosimann B, Surbek D. Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial. Lancet Diabetes Endocrinol 2025; 13: 591–99—In this Article, the time above range percentage for the SMGB control group in table 4 should have been 2·3%. This correction has been made to the online version as of Dec 22, 2025.